邓志军,郭洁文,杨敏,潘竞锵,曾英彤
DENG Zhi-jun1,GUO Jie-wen2, YANG Min3, PAN Jing-qiang2 , ZENG Ying-tong3 (1. Guangzhou University of Traditional Chinese Medicine

• 1:广州中医药大学
• 2:广州市中医医院
• 3:广东省人民医院医学研究中心、广东省心血管病研究所

摘要(Abstract)：

主要综述近五年三七总皂苷(PNS)及其活性单体三七皂苷R1、人参皂苷Rb1、人参皂苷Rg1的药动学研究进展。目前对PNS生物样品中人参皂苷Rg1,人参皂苷Rb1和三七皂苷R1等PNS活性单体的药物浓度多采用HPLC检测以评价PNS及其活性单体的药代动力学过程,现有的PNS药动学研究仅涉及PNS给药后2～3个单体皂苷,未能全面反映PNS的药动学变化规律,PNS血药浓度与药物效应关系不明确,今后的研究方向及重点应进一步研究PNS的化学成分及串联质谱法作分析手段的可行性并结合作用机制方面的研究以揭示其药动学特性及规律。
To summarize advances of pharmacokinetics study of Panax Notoginseng and active Monomers such as sanchinoside R1, ginsenoside Rb1, ginsenoside Rg1, and its dosage forms in the past 5 years. At present the sanchinoside Rg1, sanchinoside Rb1, sanchinoside R1, and other active monomers of PNS were detected by HPLC, then to evaluate the pharmacokinetics process of Panax Notoginseng and active monomers. The existing pharmacokinetics studies of PNS only involved 2 to 3 monomer saponin after administrated of PNS. It does not reflect the overall rules of pharmacokinetics changes of PNS. The relation of PNS plasma and its effect is not clear. For the future, the direction and priority should research the chemical composition of PNS and the feasibility of analyse in tandem mass spectrometry. And it should combine the mechanism of PNS to reveal the characteristic and of pharmacokinetics of PNS.

关键词(KeyWords)： 三七总皂苷;三七皂苷R1;人参皂苷Rb1;人参皂苷Rg1;药代动力学
panax notoginsenoside; sanchinoside R1; ginsenoside Rb1; ginsenoside Rg1; pharmacokinetics;

Abstract:

Keywords:

基金项目(Foundation): 广东省社会发展领域科技计划项目(编号:83100);; 广东省中医药管理局基金(编号:1060060、2008005);; 广东省医院药学研究基金(编号:2009A008);; 广州市中医药中西医结合科研(编号:2008A15)联合资助

作者(Author): 邓志军,郭洁文,杨敏,潘竞锵,曾英彤
DENG Zhi-jun1,GUO Jie-wen2, YANG Min3, PAN Jing-qiang2 , ZENG Ying-tong3 (1. Guangzhou University of Traditional Chinese Medicine

参考文献(References)：

• [1]李家实.中药鉴定学[M].上海:上海科学技术出版社,1998:132.
• [2]Dong TT,Cui XM,Song ZH,et a1.Chemical assessment of roots of Panax notoginseng in China:regio-nal and seasonal variations in its active constituents[J].J Agric Food Chen,2003,51:4617-4623.
• [3]周燕,田磊,莫宁.三七总皂苷抗心肌肥大的作用与其影响神经体液因素的关系[J].中国中药杂志,2005,30(12):916-919.
• [4]龙全江,郁洋.RP-HPLC法测定血塞通注射液中三七皂苷R1、人参皂苷Rg1、人参皂苷Rb1[J].现代中药研究与实践,2007,21(1):43-45.
• [5]宋建平,曾江,崔学明,等.三七根茎的化学成分研究(Ⅱ)[J].云南大学学报(自然科学版),2007,29(3):287-290.
• [6]陈霞,吴锋,徐济良,等.犬单剂量口服血塞通片的血浆药动学研究[J].南通大学学报,2007,27(2):115-116,120.
• [7]LiL,ZhangJ,ShengYX,etal.Liquid chromatographicmethodfordeter-mination of four active saponins from Panax notoginseng in rat urine using solid-phaseextraction[J].JChroma-togr B Analyt Technol Biomed LifeSci,2004,808(2):177-183.
• [8]Li L,SHeng Y,ZHang J,et al.HPLC determination of four active saponins from Panax notoginseng in rat serum and its application to pharmacokinetic studies[J].Biomed Chromatogr,2004,18(10):849-856.
• [9]王毅,刘铁汉,王巍,等.肠内菌群对人参皂苷Rgl的代谢转化作用的研究[J].中国中药杂志,2001,26(3):188-190.
• [10]马郁琪,李彤,肖建初,等.3H-三七皂苷Rgl在大鼠体内的药物动力学研究[J].中草药,1987,18(9):21-24.
• [11]茅向军,孙建国,吕天,等.HPLC-MS法测定犬血浆中三七皂苷R1的血药浓度及其药代动力学[J].中国临床药理学与治疗学,2005,10(7):734-737.
• [12]冯亮,蒋学华,周静,等.三七皂苷R1和人参皂苷Rgl的大鼠在体肠吸收动力学研究[J].中国药学杂志,2006,41(14):1097-1102.
• [13]杜力军,邢东明,刘美凤,等.脑血管药CBN注射剂药代动力学研究[J].世界科学技术-中医药现代化*基础研究.2003,5(1):48-52.
• [14]Liang F,Hua JX.Absorption profiles of sanchinoside R1and ginsenoside Rg1in the rat intestine[J].Eur J Drug Metab Pharmacoki-net,2005,30(4):261-268.
• [15]韩旻,韩丽妹,王青松,,等.三七皂苷的口服吸收机制[J].药学学报,2006,41(6):498-505.
• [16]Han M,Sha X,Wu Y,et al.Oralabsorption of ginsenoside Rb1using in vitro and in vivo models[J].Planta Med,2006,72(5):398-404.
• [17]Han M,Fang XL.Difference in oral absorption of ginsenosideRg1betwe-en in vitro and in vivo models[J].Acta Pharmacol Sin,2006,27(4):499-505.
• [18]Xu QF,Fang XL,Chen DF.Pharmacokineticsandbioavailabilityof ginsenoside Rb1and Rg1from Panax notoginsenginrats[J].Ethnopharmacol,2003,2-3(84):187-192.
• [19]何希辉,炎彬,潘卫松,等.三七皂苷中R1、Rgl在正常和脑缺血再灌大鼠中的动力学变化[J].中药药理与临床,2001;17(6):12-14.
• [20]陈霞,徐济良.高效液相色谱法测定犬血浆中人参皂苷Rg1的浓度[J].中国医院药学杂志,2007,27(2):174-175
• [21]沈央,方晓玲.三七总皂苷脂质体的药剂学性质及大鼠肺部给药药动学研究[J].中草药,2004,35(7):745-749.
• [22]Xiong J,Guo J,Huang L,et al.The use of lipid-based formulations to increase the oral bioavailability of Panax notoginseng saponins follo-wing a single oral gavage to rats[J].Drug Dev Ind Pharm,2008,34(1):65-72.
• [23]Xiong J,Guo J,Huang L,et al.Self-micelleformationandtheincor-poration of lipid in the formulation affect the intestinal absorption of Panax notoginseng[J].Int J Pharm,[[[[[[[[[2008,360(1-2):191-196.
• [24]张梅,宋芹,钟花,等.三七水凝胶透皮贴剂的初步研究[J].成都中医药大学学报,2005,28(5):60-61.
• [25]徐白,沈蕴琪,方晓玲,等.三七总皂苷复方脂质体凝胶剂的制备及皮肤给药研究[J].中国临床药学杂志,2007,16(3):144-148.
• [26]吴云娟,朱晓艺,沙先谊,等.三七总皂苷鼻腔给药的药代动力学和药效学[J].药学学报,2005,40(4):377-381.
• [27]韩旻,付韶,方晓玲.三七总皂苷油包水微乳的处方筛选及体内外评价[J].药学学报,2007,42(7):780-786.
• [28]陈霞,徐济良.血塞通分散片的生物利用度评价[J].时珍国医国药,2007,18(8):1852-1853.
• [29]赵文萃,王艳萍,薛万俐,等.血塞通注射液中人参皂苷Rb1的药动学研究[J].药学实践杂志,2007,25(3):152-153,158.
• [30]陈卫,朱春燕.三七总皂苷药物动力学及体内代谢研究进展[J].中南药学,2005,3(1):32-35.
• [31]郭洁文,杨敏,朱剑光,等.三七总皂苷对心血管作用的药理研究新进展[J].现代食品与药品杂志,2007,17(2):1-4.
• [32]郭洁文,邓志军,符永恒,等.三七总皂苷对心梗后心室重构大鼠增强抗氧化与改善心肌形态学作用[J].中山大学学报(自然科学版),2008,47(2):140-142.